Retention of reversibly thermo-gelling timolol on the human ocular surface studied by video meniscometry

Author: Ishibashi Takeshi   Yokoi Norihiko   Bron Anthony J.   Tiffany John M.   Komuro Aoi   Kinoshita Shigeru  

Publisher: Informa Healthcare

ISSN: 0271-3683

Source: Current Eye Research, Vol.27, Iss.2, 2003-08, pp. : 117-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Purpose. To investigate the retention of reversibly thermo-gelling timolol (TG-timolol) on the human ocular surface using video meniscometry. Methods. The study population consisted of 14 healthy volunteers with no external eye disease. Fifteen μl TG-timolol were instilled into one eye of each subject and the same volume of aqueous, timolol ophthalmic solution was instilled in the fellow eye, in a masked fashion. Tear meniscus curvature was monitored at the center of the lower meniscus in each eye, using a newly-developed video meniscometer, before and at one-minute intervals for ten minutes after, the instillation. The radius of meniscus curvature (R) was calculated from printed video-images using the concave mirror formula. The change in R with time after instillation was compared for the two groups. Results. The change in meniscus radius with time t [defined as ?R(t) = R(t) – R(0)] showed a significant exponential regression in both the TG-timolol and the timolol groups. There was a significant difference in the value of ?R(5) and ?R(10) between eyes with TG-timolol [?R(5) = 0.29mm, ?R(10) = 0.18mm] and eyes with timolol only [?R(5) = 0.10mm, ?R(10) = 0.06mm] [?R(5): P < 0.001, ?R(10): P < 0.001]. The area under each regression curve of ?R(t), an indicator of vehicle retention, was greater in the eyes treated with TG-timolol than in those receiving timolol only (2.09 vs. 0.56, P < 0.001). Conclusions. The present study demonstrated that the reversibly thermo-gelling timolol was better retained at the ocular surface than conventional, aqueous timolol.

Related content